All Stories

  1. Blood DNA Methylation in Nuclear and Mitochondrial Sequences Links to Malnutrition and Poor Prognosis in ALS: A Longitudinal Study

    Article • Nutrients, April 2025, MDPI AG

    Dr JULIO PARDO

  2. Guía práctica de diagnóstico y manejo en la enfermedad de Charcot-Marie-Tooth en España

    Article • Neurología, April 2025, Elsevier

    Dr JULIO PARDO

  3. Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study

    Article • European Journal of Neurology, July 2024, Wiley

    Dr JULIO PARDO

  4. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Article • Neuromuscular Disorders, January 2024, Elsevier

    Dr JULIO PARDO

  5. Miastenia gravis. Actualización diagnóstica y terapéutica

    Article • Medicina Clínica, August 2023, Elsevier

    Dr JULIO PARDO

  6. Mapa epidemiológico transversal de las ataxias y paraparesias espásticas hereditarias en España

    Article • Neurología, July 2023, Elsevier

    Dr JULIO PARDO

  7. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

    Article • Neurology, June 2023, Wolters Kluwer Health

    Dr JULIO PARDO

  8. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    Article • European Journal of Neurology, January 2023, Wiley

    Dr JULIO PARDO

  9. Epidemiología de la miastenia grave en la península ibérica y Latinoamérica

    Article • Revista de Neurología, January 2023, IMR Press

    Dr JULIO PARDO

  10. Cumulative genetic risk andC9orf72repeat status independently associate with ALS status in two case-control studies

    Article • October 2022, Cold Spring Harbor Laboratory Press

    Dr JULIO PARDO

  11. An International Perspective on Preceding Infections in Guillain-Barré Syndrome

    Article • Neurology, September 2022, Wolters Kluwer Health

    Dr JULIO PARDO

  12. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values

    Article • Clinical Neurophysiology, June 2022, Elsevier

    Dr JULIO PARDO

  13. International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score

    Article • Annals of Neurology, February 2022, Wiley

    Dr JULIO PARDO

  14. Predicting Outcome in Guillain-Barré Syndrome

    Article • Neurology, February 2022, Wolters Kluwer Health

    Dr JULIO PARDO

  15. Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

    Article • Annals of Clinical and Translational Neurology, January 2022, Wiley

    Dr JULIO PARDO

  16. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy

    Article • Neurology Neuroimmunology & Neuroinflammation, January 2022, Wolters Kluwer Health

    Dr JULIO PARDO

  17. Autoantibody screening in Guillain–Barré syndrome

    Article • Journal of Neuroinflammation, November 2021, Springer Science + Business Media

    Dr JULIO PARDO

  18. Autoantibody screening in Guillain-Barré Syndrome

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Dr JULIO PARDO

  19. Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis

    Article • European Journal of Neurology, March 2021, Wiley

    Dr JULIO PARDO

  20. Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4

    Article • Journal of Neurology, January 2021, Springer Science + Business Media

    Dr JULIO PARDO

  21. Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2020, BMJ

    Dr JULIO PARDO

  22. Cerebellar Cognitive Affective Syndrome in Costa da Morte Ataxia (SCA36)

    Article • The Cerebellum, April 2020, Springer Science + Business Media

    Dr JULIO PARDO

  23. Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients

    Article • March 2020, Cold Spring Harbor Laboratory Press

    Dr JULIO PARDO

  24. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset

    Article • Neurology, March 2020, Wolters Kluwer Health

    Dr JULIO PARDO

  25. Respuesta clínica y neurofisiológica a la efedrina en un paciente con síndrome miasténico congénito de canal lento

    Article • Revista de Neurología, January 2020, IMR Press

    Dr JULIO PARDO

  26. Current treatment practice of Guillain-Barré syndrome

    Article • Neurology, June 2019, Wolters Kluwer Health

    Dr JULIO PARDO

  27. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Article • Journal of Neurology Neurosurgery & Psychiatry, December 2018, BMJ

    Dr JULIO PARDO, Giorgio Tasca

  28. Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations

    Article • Journal of Medical Genetics, November 2018, BMJ

    Dr JULIO PARDO

  29. Regional variation of Guillain-Barré syndrome

    Article • Brain, September 2018, Oxford University Press (OUP)

    Dr JULIO PARDO

  30. Inflammatory myopathy in the context of an unusual overlapping laminopathy

    Article • Archives of Endocrinology and Metabolism, May 2018, Archives of Endocrinology and Metabolism

    Dr JULIO PARDO

  31. The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis

    Article • Annals of Clinical and Translational Neurology, April 2018, Wiley

    Dr JULIO PARDO

  32. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

    Article • Journal of Neuroinflammation, November 2017, Springer Science + Business Media

    Dr JULIO PARDO

  33. Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain

    Article • Scientific Reports, July 2017, Springer Science + Business Media

    Dr JULIO PARDO

  34. Phenotypical features of a new dominant GDAP1 pathogenic variant (p.R226del) in axonal Charcot-Marie-Tooth disease

    Article • Neuromuscular Disorders, July 2017, Elsevier

    Dr JULIO PARDO

  35. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

    Article • Journal of the Peripheral Nervous System, June 2017, Wiley

    Dr JULIO PARDO

  36. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36

    Article • Movement Disorders, November 2016, Wiley

    Dr JULIO PARDO

  37. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital disch...

    Article • BMC Neurology, May 2016, Springer Science + Business Media

    Dr JULIO PARDO

  38. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins

    Article • Neurology Neuroimmunology & Neuroinflammation, September 2015, Wolters Kluwer Health

    Dr JULIO PARDO

  39. Analysis of theCHCHD10gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain

    Article • Brain, July 2015, Oxford University Press (OUP)

    Dr JULIO PARDO

  40. Gastrointestinal symptoms in late-onset Pompe disease: Early response to enzyme replacement therapy

    Article • Journal of the Neurological Sciences, June 2015, Elsevier

    Dr JULIO PARDO

  41. Neuropatías, radiculopatías y plexopatías

    Article • Medicine - Programa de Formación Médica Continuada Acreditado, May 2015, Elsevier

    Dr JULIO PARDO

  42. Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry

    Article • European Journal of Neurology, April 2015, Wiley

    Dr JULIO PARDO

  43. Successful treatment of hypokalemic periodic paralysis with topiramate

    Article • European Journal of Neurology, July 2014, Wiley

    Dr JULIO PARDO

  44. Can we predict the response in the treatment of epilepsy with vagus nerve stimulation?

    Article • Neurosurgical Review, May 2014, Springer Science + Business Media

    Dr JULIO PARDO

  45. Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome

    Article • Journal of Clinical Neuroscience, May 2014, Elsevier

    Dr JULIO PARDO

  46. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: A retrospective study

    Article • Muscle & Nerve, September 2013, Wiley

    Dr JULIO PARDO

  47. A novel mutation, outside of the candidate region for diagnosis, in the inverted formin 2 gene can cause focal segmental glomerulosclerosis

    Article • Kidney International, January 2013, Elsevier

    Dr JULIO PARDO

  48. Analysis of theC9orf72Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide

    Article • Human Mutation, October 2012, Wiley

    Jordi Clarimon, Dr JULIO PARDO

  49. Diagnóstico y tratamiento del dolor neuropático

    Article • Medicina Clínica, October 2009, Elsevier

    Dr JULIO PARDO

  50. Two-stage case-control association study of dopamine-related genes and migraine

    Article • BMC Medical Genetics, January 2009, Springer Science + Business Media

    Dr JULIO PARDO

  51. Distinct phenotypic features and gender-specific disease manifestations in a Spanish family with desmin L370P mutation

    Article • Neuromuscular Disorders, August 2006, Elsevier

    Dr JULIO PARDO

  52. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists

    Article • Neurological Sciences, June 2004, Springer Science + Business Media

    Dr JULIO PARDO

  53. Guillain-Barré Syndrome in Spain, 1985–1997: Epidemiological and Public Health Views

    Article • European Neurology, January 2001, Karger Publishers

    Dr JULIO PARDO

  54. P134 Electroneurographic (ENoG) evaluation of peripheral facial palsy (PFP). Early and late results in 500 patients

    Article • Electroencephalography and Clinical Neurophysiology, October 1996, Elsevier

    Dr JULIO PARDO

  55. Bone anomalies in myotonic dystrophy

    Article • Acta Neurologica Scandinavica, June 1991, Wiley

    Dr JULIO PARDO